1. The reassessment of trial perspectives from interim data-a critical review;Bauer;Statistics in Medicine,2006
2. Berry, D. A. (2001). Adaptive Trials and Bayesian Statistics in Drug Development (with Comments). Winter 2001 Biopharmaceutical Report of Biopharmaceutical Section. American Statistical Association, 1-11.
3. Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI type II coronary intervention study;Brensike;Circulation,1984
4. Chi, G., Hung, H. M. J., and O'Neill, R. (2001). Some Comments on “Adaptive Trials and Bayesian Statistics in Drug Development” by Donald A. Berry. Winter 2001 Biopharmaceutical Report of Biopharmaceutical Section. American Statistical Association, 7-9.
5. Monitoring clinical trials based on predictive probability of significance;Choi;Biometrics,1989